Staburo @ DAGStat 2022

Staburo @ DAGStat 2022

Staburo @ DAGStat 2022 in Hamburg 

Staburo statisticians joined the DAGStat conference 2022 in Hamburg, March 28 to April 1, hosted at the University Medical Center Hamburg-Eppendorf. One goal of the joint statistical meeting of the German Consortium for Statistics (Deutsche Arbeitsgemeinschaft Statistik, DAGStat) is to stimulate constructive discussions between the representatives of the various statistical areas summarized by the DAGStat theme >>Statistics under one umbrella<< (an umbrella being a conference present in Hamburg 😉). This year, the central DAGStat theme was complemented by the motto >>Mind the gap – Interplay between theory and practice<<. In this sense the Staburo statisticians updated themselves about current research topics which could be applied to biostatistical questions in their daily work. Research areas of interest included: Design of experiments and clinical trials, clustering and classification, statistics in the pharmaceutical and medical device industry, survival and event history analysis, the STRATOS (STRengthening Analytical Thinking for Observational Studies) initiative, causal inference, robustness of statistical conclusions, and cross-validation. As a lesson learned from SARS-CoV-2 pandemic and climate change, with extreme weather events, the role and importance of statistics and data science to science and society, and the need to prepare for future challenges was intensely discussed.

Data analysis, clinical biostatistics and more.

Publication @ Staburo: Treatment of Oropharyngeal Symptoms: A Prospective, Single-Dose, Placebo-Controlled, Randomized Clinical Trial

Publication @ Staburo: Treatment of Oropharyngeal Symptoms: A Prospective, Single-Dose, Placebo-Controlled, Randomized Clinical Trial

Staburo contributed data science expertise to medical device study 

Staburo supported the German pharmaceutical company, Dr. Pfleger Arzneimittel GmbH, Bamberg, during the whole lifecycle of the ‘ipalat® Hydro Med’ study in terms of protocol writing, randomisation, statistical analysis plan writing, statistical programming, report and publication writing. The prospective, single-dose, placebo-controlled, randomized clinical trial investigated whether sucking and chewing the ‘ipalat® Hydro Med’ pastille (class I, CE-certified medical device) containing a specific mixture of four different polysaccharides provides instantaneous relieving effects for acute oropharyngeal symptoms such as sore throat, difficulty swallowing, hoarseness, tickly throat, and dry mouth. Find out more about the study results being published here https://doi.org/10.2147/OAJCT.S331883

Data analysis, clinical biostatistics and more.